Browse Related Topics For:

The United States Food and Drug Administration

868
Pharmaceutical Industry
618
Medical Devices
482
Prescription Drugs
328
Biosimilars
323
Food Labeling
295
Healthcare
251
Patents
227
Pharmaceutical Patents
220
FDCA
220
Generic Drugs
211
Manufacturers
209
BPCIA
202
Food Manufacturers
200
Food Safety
189
Draft Guidance
177
Popular
167
Affordable Care Act
167
HHS
158
Patent Litigation
153
Patent Infringement
149
CMS
136
Biologics
131
Off-Label Promotion
129
Labeling
128
ANDA
128
FTC
126
False Advertising
125
Advertising
125
Amgen
122
FSMA
121
SCOTUS
115
Medicare
113
Preemption
105
GMO
102
Sandoz
101
First Amendment
100
Medicaid
96
Cybersecurity
94
Class Action
93
Health Care Providers
92
Hatch-Waxman
92
Sandoz v Amgen
91
USDA
83
FDA Approval
82
Clinical Trials
79
Biotechnology
79
EPA
75
Legislative Agendas
75
Life Sciences
72
Off-Label Use
71
Comment Period
68
Marketing
65
Nutrition Facts Labels
64
21st Century Cures Initiative
62
Preliminary Injunctions
61
Final Rules
60
DOJ
59
NIH
59
Warning Labels
58
Pharmacies
55
Amarin
55
Final Guidance
54
Appeals
54
Misbranding
53
Enforcement Actions
52
Product Labels
51
Drug Compounding
51
Patent Dance
50
Public Comment
49
HIPAA
49
Lanham Act
49
New Guidance
48
False Claims Act (FCA)
48
Hospitals
47
CDC
47
Commercial Marketing
47
Dietary Supplements
46
Natural Products
45
POM Wonderful
44
Apotex
44
Failure To Warn
43
Mobile Apps
41
Free Speech
40
FFDCA
39
Health Insurance
39
Physicians
38
All Natural
38
Food Contamination
38
Food Marketing
38
Restaurant Industry
37
510(k) RTA
37
Coca Cola
37
Corporate Counsel
36
Laboratory Developed Tests
36
Reporting Requirements
36
Warning Letters
35
Drug Pricing
35
POM Wonderful v Coca Cola
35
Social Media
35
Trump Administration
34
Product Recalls
33
FCC
33
FD&C Act
33
Premarket Approval Applications
33
Proposed Legislation
33
Proposed Regulation
32
E-Cigarettes
32
Notice Requirements
32
Risk Management
31
EU
31
Medical Research
31
Safe Harbors
30
Chemicals
30
Commercial Speech
30
GAO
30
Toxic Substances Control Act (TSCA)
29
aBLA
28
Diagnostic Tests
28
Healthcare Reform
28
HELP
28
Nanotechnology
27
Data Protection
27
Food Recalls
27
Health Information Technologies
27
Medicare Part D
27
NLEA
27
OIG
27
Software
27
Unfair Competition
26
Enforcement
26
FDASIA
26
FIFRA
26
Pending Legislation
26
Public Meetings
26
Putative Class Actions
26
Telemedicine
25
Cancer
25
Compliance
25
Drug Safety
25
Patent-in-Suit
25
Supply Chain
24
3D Printing
24
Barack Obama
24
Congressional Investigations & Hearings
24
OSTP
24
Technology
23
AbbVie
23
Dismissals
23
Imports
23
IRS
23
Personalized Medicine
23
Product Defects
23
Regulatory Agenda
23
Settlement
23
Summary Judgment
23
Unfair or Deceptive Trade Practices
22
Clinical Laboratories
22
Cosmetics
22
Innovation
22
Johnson & Johnson
21
Biologics Price Competition and Innovation Act of 2009
21
FDA Warning Letters
21
Menu-Labeling
21
mHealth
21
ONC
21
SEC
20
Citizen Petitions
20
Digital Health
20
EHR
20
Medicare Part B
20
Misleading Statements
20
Multidistrict Litigation
20
Mylan Pharmaceuticals
20
Orphan Drugs
20
Research and Development
19
CHIP
19
Declaratory Judgments
19
Design Defects
19
Fraud
19
Jurisdiction
19
Mobile Health Apps
19
Patent Applications
19
PHRMA
19
Public Health Service Act
18
21st Century Cures Act
18
Criminal Prosecution
18
Disclosure Requirements
18
Farms
18
Hackers
18
Pesticides
18
Public Health
18
Recordkeeping Requirements
18
USPTO
18
Wine & Alcohol
17
CERCLA
17
CGMP
17
Class Certification
17
CLIA
17
Contraceptive Coverage Mandate
17
DNA
17
DSCSA
17
Federal Register
17
Grocery Stores
17
Mental Health
17
Motion to Dismiss
17
Obama Administration
17
OMB
17
PHI
17
Product Packaging
17
RCRA
17
Regulatory Oversight
17
Risk Assessment
17
Whistleblowers
16
Adverse Events
16
Antitrust Litigation
16
Caronia
16
Consumer Product Safety Commission (CPSC)
16
Data Breach
16
GlaxoSmithKline
16
Health Insurance Exchanges
16
Hospira
16
Medicare Access and CHIP Reauthorization (MACRA)
16
Medtronic
16
New Legislation
16
Obviousness
16
Prior Art
16
Qui Tam
16
Regulatory Standards
16
Section 340B
16
Standing
16
Substance Abuse
15
Bayer
15
Clean Air Act
15
Clean Water Act
15
Contraceptives
15
DQSA
15
HRSA
15
Injunctive Relief
15
Medicare Advantage
15
Misleading Impressions
15
NIST
15
OSHA
15
Personal Care Products
15
Retailers
15
Tobacco
15
Trademarks
15
Trans Fat
15
Unique Device Identifiers
15
Zika
14
Data Collection
14
Discovery
14
Evaporated Cane Juice
14
Inter Partes Review (IPR) Proceeding
14
Legislative Committees
14
Reverse Payment Settlement Agreements
14
Social Networks
14
Teva Pharmaceuticals
14
Tobacco Regulations
14
Wellness Programs
13
Animal Food
13
Cyber Attacks
13
Data Security
13
DOL
13
Drug & Alcohol Abuse
13
Electronic Medical Records
13
Federal Budget
13
FSVP
13
Janssen Pharmaceuticals
13
OCR
13
Opioid
13
Organic
13
Patent Invalidity
13
Personal Jurisdiction
13
PHSA
13
Pleading Standards
13
PLIVA v Mensing
13
Precision Medicine Initiative (PMI)
13
Product Exclusivity
13
Rulemaking Process
12
ACOs
12
App Developers
12
Certiorari
12
China
12
Civil Monetary Penalty
12
Controlled Substances Act
12
DEA
12
Distributors
12
Exemptions
12
Federal Funding
12
GRAS
12
Intellectual Property Protection
12
Marijuana
12
Medical Device Accessories
12
Merck
12
Nutritional Supplements
12
Orange Book
12
Patient Safety
12
World Health Organization
11
Allergan Inc
11
Birth Defects
11
Canada
11
Causation
11
Children's Products
11
Fast-Food Industry
11
FTC v Actavis
11
General Mills
11
Genetic Testing
11
Healthcare Facilities
11
Informed Consent
11
IRIS
11
Learned Intermediary
11
Long Term Care Facilities
11
Medicaid Expansion
11
Negligence
11
OECD
11
Pfizer
11
Prescription Drug Coverage
11
Primary Jurisdiction Doctrine
11
Professional Conferences
11
Salmonella
11
Scientific Research
11
Vaccinations
11
Veterinary Products
10
Additive Manufacturing
10
Administrative Procedure Act
10
Anti-Kickback Statute
10
Antibiotics
10
DHS
10
Dole Food
10
Fifth Amendment
10
Gluten-Free
10
Healthcare Fraud
10
Information Sharing
10
Infringement
10
Inspections
10
Interstate Commerce
10
Investigational New Drug procedures (IND)
10
Medical Marijuana
10
MedPAC
10
Menu Rule
10
Misrepresentation
10
Mobile Devices
10
New Regulations
10
Personally Identifiable Information
10
Public Hearing
10
REMS
10
Risk Mitigation
10
Safety Precautions
10
Side Effects
10
Telehealth
10
Transparency
10
Transvaginal Mesh
10
Young Lawyers
9
23andMe
9
Actavis Inc.
9
America Invents Act
9
Antitrust Violations
9
Black Box Warnings
9
Celebrity Endorsements
9
CLRA
9
Copyright
9
Cyber Threats
9
Databases
9
Drug Approvals
9
Drug Distribution
9
Employee Benefits
9
ERISA
9
Excise Tax
9
Expert Testimony
9
FOIA
9
Guidance Update
9
Home Health Care
9
Internet of Things
9
Investigational Device Exemptions
9
Investors
9
Listeria
9
Medical Device Data System
9
Patients
9
Pay-For-Delay
9
Repeal
9
Retail Market
9
Sherman Act
9
Sunshine Act
9
Wage and Hour
9
Wearable Technology
8
Animal Drugs
8
Anti-Competitive
8
Appropriations Bill
8
Attorney Generals
8
Beverage Manufacturers
8
Breach of Warranty
8
Cost-Sharing
8
Ebola
8
European Medicines Agency (EMA)
8
Exports
8
Food Supply
8
Foreign Suppliers
8
Genetically Engineered Seed
8
Google
8
Homeopathic Remedies
8
Internet
8
Medical Malpractice
8
Mobile Medical Applications
8
Modification
8
NAD
8
Outsourcing
8
Patent Trial and Appeal Board
8
PDUFA
8
Petition for Writ of Certiorari
8
Physician Medicare Reimbursements
8
Salmon
8
SAMHSA
8
Securities Litigation
8
Shipping
8
Skilled Nursing Facility
8
SNUR
8
Stark Law
8
Stem cells
8
The Common Rule
8
Trucking Industry
7
Abbott Laboratories
7
Acquisitions
7
Advisory Committee
7
Amicus Briefs
7
Classen Immunotherapies
7
Congressional Committees
7
COPPA
7
Covered Entities
7
Customs and Border Protection
7
Eli Lilly
7
Employer Mandates
7
European Commission
7
European Food Safety Authority (EFSA)
7
FCPA
7
General Wellness Devices
7
Genetically Engineered Animals
7
Government Shutdown
7
HCEI
7
HITECH
7
Illegal Drugs
7
Infectious Diseases
7
IRB
7
Kellogg Company
7
Kim Kardashian
7
Licensing Rules
7
Mergers
7
Nanomaterials
7
Novartis
7
On-Sale Bar
7
Pain Management
7
Pregnancy
7
Product Hopping
7
Proposition 65
7
Public Health Insurance Marketplace
7
Public Safety
7
Punitive Damages
7
Qualified Health Plans
7
Registration
7
School Lunch Programs
7
Secretary of HHS
7
Securities Fraud
7
Toxic Chemicals
7
UK
7
Watson Pharmaceuticals
7
Websites
7
Whole Foods
6
ADA
6
American Medical Association
6
Article III
6
Biobased Chemicals
6
Bioengineering
6
Blue Bell Creameries
6
Brand
6
Breweries
6
Burwell v Hobby Lobby
6
Chobani Inc
6
Clean Power Plan
6
Competition
6
ConAgra
6
Consumer Fraud
6
Department of Transportation (DOT)
6
Department of Veterans Affairs
6
EEOC
6
Elan Pharmaceuticals
6
Exclusivity
6
False Statements
6
Federal Rules of Civil Procedure
6
Fiduciary Duty
6
Hobby Lobby
6
Human Genes
6
Importers
6
Inadequate Warning
6
Insider Trading
6
Insurance Industry
6
Interchangeability
6
Kickbacks
6
Legal Perspectives
6
Licenses
6
Manufacturing Defects
6
Mutual Pharmaceuticals v Bartlett
6
Negligent Misrepresentation
6
OPDP
6
OPPS
6
Otsuka Pharmaceutical
6
Over-the-Counter Sales
6
Patient Privacy Rights
6
Personal Liability
6
Privacy Concerns
6
Privacy Policy
6
Public Disclosure
6
Purple Book
6
Registration Requirement
6
Samsung
6
Shareholders
6
Soda Tax
6
Suppliers
6
Tax Credits
6
Twitter
6
Waters of the United States
6
Wrongful Death
5
Amended Regulation
5
Animal Health
5
Antibiotic Resistance
5
Antitrust Provisions
5
Attorney-Client Privilege
5
Audits
5
Big Data
5
Biopharmaceutical
5
Bodily Injury
5
Breach Notification Rule
5
Burden of Proof
5
Cadillac Tax
5
CEOs
5
Claim Construction
5
Climate Change
5
Confidential Information
5
Contamination
5
Continuing Resolution
5
Cyber Crimes
5
Data Privacy
5
Disgorgement
5
Do Not Track
5
Durable Medical Equipment
5
EAP
5
Elder Issues
5
Endo Pharmaceuticals
5
ESRD
5
Facebook
5
Farm Animals
5
Farm Bill
5
Federal Rule 12(b)(6)
5
Food Allergies
5
Genetic Materials
5
Gerber
5
Government Investigations
5
Greenhouse Gas Emissions
5
Health Claims
5
Hospitality Industry
5
Human Genome Project
5
ICD-10
5
Indictments
5
Injunctions
5
Investigational New Drug Application (IND)
5
Liability Insurance
5
Marijuana Cultivation
5
Mass Tort Litigation
5
Monopolization
5
National Academy of Sciences (NAS)
5
National Cancer Moonshot
5
Nursing Homes
5
OFAC
5
Office of Chemical Safety & Pollution Prevention (OCSPP)
5
Omnicare
5
Open Enrollment
5
OTC
5
Park Doctrine
5
Patent-Eligible Subject Matter
5
Permanent Injunctions
5
Presidential Elections
5
Product Development Protocols
5
Proposed Amendments
5
Reimbursements
5
Renewable Energy
5
Request For Information
5
Right of Publicity
5
Risk-Based Approaches
5
Safety Standards
5
Sanctions
5
Sanitary Food Transportation Act (SFTA)
5
Scams
5
Scientific Evidence
5
Seafood
5
Settlement Agreements
5
Subway
5
Toxic Exposure
5
Trade Secrets
5
Unjust Enrichment
5
User Fees
5
Veterans
5
Whistleblower Protection Policies
5
Wholesale
5
Wyeth
4
Abortion
4
Allergan v Sandoz
4
Anheuser-Busch
4
Anti-Retaliation Provisions
4
Antimicrobials
4
APHIS
4
Beer
4
Best Practices
4
Biogen Idec
4
Boehringer
4
Carbon Nanotubes
4
CCIIO
4
Celiac Disease
4
Celltrion
4
Center for Drug Evaluation and Research (CDER)
4
Cephalon
4
Chipotle Grill
4
Commercial Truck Drivers
4
Consumer Protection Act
4
Controlled Substances
4
Corporate Officers
4
Cyber Insurance
4
Damages
4
Data-Sharing
4
Daubert Standards
4
Declaratory Relief
4
Department of Defense (DOD)
4
DOE
4
Drinking Water
4
Employer Liability Issues
4
European Court of Justice (ECJ)
4
Executive Orders
4
Financial Conduct Authority (FCA)
4
FLSA
4
Foreign Manufacturers
4
FTC Act
4
Fungal Meningitis
4
GDUFA
4
Generic
4
GNC
4
Hazardous Substances
4
Hazardous Waste
4
Health and Safety
4
Health IT
4
Health Safety
4
Hospice
4
Human Rights
4
Information Reports
4
Inpatient Prospective Payment System (IPPS)
4
Intellectual Property Litigation
4
Inventors
4
IP License
4
Jury Trial
4
Laboratories
4
Managed Care Contracts
4
Marijuana Related Businesses
4
Medical Reimbursement
4
Memorandum of Understanding
4
Mensing
4
Method Claims
4
Minors
4
Mootness
4
Native American Issues
4
Nestle
4
NFL
4
NIOSH
4
NLRB
4
No-AG Agreement
4
NPRM
4
Nurses
4
Oil & Gas
4
openFDA
4
OxyContin
4
Patient-Specific
4
Penalties
4
Pharmacist
4
Physician Fee Schedule
4
Physician SGR Formula
4
Post-Grant Review
4
Preventive Health Care
4
Private Right of Action
4
PSLRA
4
Quality Control Plan
4
Relators
4
Religion
4
Religious Freedom Restoration Act
4
Right to Try
4
Ripeness
4
Section 503
4
Securities Exchange Act
4
Small Business
4
Smartphones
4
Solicitor General
4
Starbucks
4
Startups
4
State Law Claims
4
Statute of Limitations
4
Strategic Enforcement Plan
4
Strict Liability
4
Subject Matter Jurisdiction
4
Subsidies
4
Telemarketing Sales Rule
4
Training
4
Twombly/Iqbal Pleading Standard
4
U.S. Treasury
4
UAW
4
Unfair Competition Law (UCL)
4
Venture Capital
4
Veterinarians
4
Wal-Mart
4
Webinars
4
WTO
4
Yates Memorandum
3
ALJ
3
All Writs Act
3
Alternative Payment Models (APM)
3
Amgen v Sandoz
3
AMP v Myriad
3
Anti-Steering Rules
3
Applications
3
Arbitration
3
Asbestos
3
AstraZeneca
3
Attorney's Fees
3
Automotive Industry
3
Aviation Industry
3
Baby Products
3
Biometric Information
3
Board of Directors
3
BPA
3
Breach of Contract
3
Breach of Duty
3
Bribery
3
Bristol-Myers Squibb
3
Capital Raising
3
Certifications
3
CFPB
3
Chevron Deference
3
Clear and Convincing Evidence
3
Clinical Laboratory Testing
3
Co-Op
3
Combination Products
3
Compensatory Damages
3
Competitive Bidding
3
Complete Genomics
3
Conflicts of Interest
3
Congressional Review Act
3
Conversion
3
Corporate Integrity Agreement
3
Corrective Actions
3
Counterfeit Drugs
3
Crops
3
Cross-Border Transactions
3
Dairy Farmers
3
Data Integrity
3
Department of Agriculture
3
Derivation Proceeding
3
Disclaimers
3
Disclosure
3
Discussion Draft
3
Dispute Resolution
3
DMEPOS
3
Due Process
3
EAR
3
ECHA
3
Electronic Health Record Incentives
3
Electronically Stored Information
3
Email
3
Employer Group Health Plans
3
Endangered Species Act (ESA)
3
Energy Sector
3
Enforcement Guidance
3
Enrollment
3
Environmental Policies
3
Ethics
3
Evidence
3
Exclusive Dealing Agreements
3
FDAMA
3
Federal Contractors
3
Fee-for-Service
3
Fees
3
Financial Markets
3
Flame Retardant
3
FMCSA
3
Food & Drug Regulations
3
Foreign Investment
3
Fracking
3
Frito-Lay
3
General Electric
3
Genzyme
3
GINA
3
GMO Bans
3
Good Clinical Practices
3
GPOs
3
HCPCS
3
Healthcare.gov
3
HEAT
3
Hersheys
3
Hiring & Firing
3
HIV
3
Individual Mandate
3
Induced Infringement
3
Information Technology
3
Infrastructure
3
Innovator Liability
3
Inpatient Rehab Facilities
3
International Harmonization
3
Justice Scalia
3
Kraft
3
Lautenberg Act
3
Law Matters
3
License Agreements
3
Local Ordinance
3
Long-Term Care
3
Malware
3
Medical Foods
3
Medicare Modernization Act
3
Meningitis
3
Minimum Salary
3
Minimum Wage
3
Monster Energy Drinks
3
NLRA
3
Notice Provisions
3
Notification Requirements
3
Office for Human Research Protections (OHRP)
3
Online Advertisements
3
Online Platforms
3
Order to Stay
3
Outsourcing Facilities
3
Over-Time
3
PAMA
3
Patient Prospective Payment System
3
PHMSA
3
Podcasts
3
Policy Exclusions
3
Pollinators
3
Power Plants
3
Premiums
3
Privacy Laws
3
Product Enhancements
3
Property Damage
3
Proposed Rules
3
Provider Payments
3
Public Schools
3
Publicly-Traded Companies
3
Rebates
3
Red Bull
3
Religious Exemption
3
Research Funding
3
Responsible Corporate Officer Doctrine
3
Reversal
3
Right to Privacy
3
Robocalling
3
Rule-of-Reason Analysis
3
Safety Inspections
3
Sanofi
3
Scienter
3
Sealed Records
3
Securities
3
Securities Violations
3
SNDAs
3
Software Developers
3
Spectrum
3
Standard of Care
3
State Health Insurance Exchanges
3
State Law Tort Claims
3
Surveillance
3
Takeda Pharmaceuticals
3
Tax Deductions
3
Tax Extenders
3
TCPA
3
Technology Sector
3
Testing Requirements
3
Third-Party
3
Third-Party Service Provider
3
Tips
3
Tobacco Litigation
3
Trade Associations
3
Trademark Infringement
3
Trader Joes
3
Traumatic Brain Injuries
3
TRO
3
TTB
3
Two-Midnight Rule
3
UK Brexit
3
Verification Requirements
3
Weight-Loss Products
3
Wireless Technology
3
Work Product Privilege
3
Working Groups
3
Yahoo!
3
YouTube
2
401k
2
Accreditation
2
Acquisition Agreements
2
Acquittals
2
Actual Injuries
2
Administrative Appointments
2
Administrative Stay
2
Advanced Notice of Proposed Rulemaking (ANPRM)
2
Aetna
2
Affirmative Defenses
2
Agricultural Sector
2
AHRQ
2
Alcohol Beverage Control
2
Algorithms
2
Alzheimer's
2
Ambulatory Surgery Centers
2
American Cancer Society
2
Amgen v Apotex
2
Animal Testing
2
Antitrust Injuries
2
Appellate Review
2
Artificial Intelligence
2
Ascertainable Class
2
Asia
2
Assisted Living Facility
2
ASTM
2
Australia
2
Bad Faith
2
Banks
2
Bellwether Verdicts
2
Benefit Plan Sponsors
2
Best Management Practices
2
Bifurcation
2
Bioproducts
2
BIS
2
Blue Diamond Growers
2
BPCI
2
BRCA
2
Brokers
2
Business Associates
2
C-Suite Executives
2
CA Supreme Court
2
CFDA
2
CFIUS
2
Childrens' Motrin
2
Chiropractors
2
Choice-of-Law
2
Cipro
2
CISO
2
Citizen Suits
2
Classification
2
Climate Action Plan
2
Clinical Evaluations
2
Closely Held Businesses
2
CLS Bank v Alice Corp
2
CMMI
2
Commercial General Liability Policies
2
Compelled Speech
2
Congressional Budget Office
2
Congressional Reports
2
Consolidated Appropriations Act
2
Consumer Product Safety Improvement Act (CPSIA)
2
Consumers Legal Remedies Act
2
Contests & Promotions
2
Contingency Fees
2
Copyright Infringement
2
Cost Recovery
2
Counterclaims
2
Country of Origin
2
Criminal Investigations
2
Criminal Liability
2
Crowdfunding
2
Cuba
2
Cuban Assets Control Regulations (CACR)
2
CVM
2
Cybersecurity Framework
2
Cybersecurity Information Sharing Act (CISA)
2
Daiichi Sankyo
2
DaimlerAG
2
DaimlerChrysler v Bauman
2
Deadlines
2
Deceptively Misdescriptive
2
Defense Sector
2
Defense Strategies
2
Delays
2
Department of Financial Services
2
DePuy Hip Replacement
2
Diagnostic Method
2
Dirks v SEC
2
Disparagement
2
Diversity Jurisdiction
2
DMCA
2
Doctrine of Equivalents
2
Dodd-Frank
2
DOMA
2
Drug Testing
2
Due Diligence
2
Duty to Deal
2
Duty to Defend
2
Economic Injuries
2
Educational Institutions
2
Electronic Communications
2
Emerging Technology Companies
2
En Banc Review
2
Enforcement Authority
2
Environmental Liability